4-methoxy-2,2,6,6-tetramethylpiperidinyl-1-oxy has been researched along with tempo in 2 studies
| Studies (4-methoxy-2,2,6,6-tetramethylpiperidinyl-1-oxy) | Trials (4-methoxy-2,2,6,6-tetramethylpiperidinyl-1-oxy) | Recent Studies (post-2010) (4-methoxy-2,2,6,6-tetramethylpiperidinyl-1-oxy) | Studies (tempo) | Trials (tempo) | Recent Studies (post-2010) (tempo) |
|---|---|---|---|---|---|
| 8 | 0 | 5 | 954 | 7 | 511 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chami, B; Dennis, JM; Fong, GM; Jeong, G; Kim, HB; Maw, AM; Rayner, BS; Simone, M; Varda, A; Wang, XS; Witting, PK | 1 |
| Bryce, SM; Dial, SL; Guo, X; Mei, N; Moore, MM; Seo, JE; Tan, JA; Wu, Q | 1 |
2 other study(ies) available for 4-methoxy-2,2,6,6-tetramethylpiperidinyl-1-oxy and tempo
| Article | Year |
|---|---|
The nitroxide 4-methoxy TEMPO inhibits neutrophil-stimulated kinase activation in H9c2 cardiomyocytes.
Topics: Animals; Apoptosis; Cell Line; Cyclic N-Oxides; Dose-Response Relationship, Drug; Enzyme Activation; Gene Expression Regulation; Humans; Myocytes, Cardiac; Neutrophils; Organ Specificity; Oxidative Stress; Peroxidase; Phosphoric Monoester Hydrolases; Phosphorylation; Protein Kinases; Protein Transport; Rats; Transferrin; Tyrosine; Ventricular Myosins | 2017 |
Comparative Genotoxicity of TEMPO and 3 of Its Derivatives in Mouse Lymphoma Cells.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Comet Assay; Cyclic N-Oxides; DNA Damage; Humans; Hydroxylamine; Mice; Mutagens; Piperidines | 2018 |